Product introduction:
Apixaban is a new oral anticoagulant (noac). It is an oral factor Xa inhibitor, which can inhibit thrombin production. It is approved for adult patients undergoing elective hip or knee replacement to prevent venous thromboembolism (VTE).
CAS:503612-47-3
Molecular formula: C25H25N5O4
Molecular weight: 459.5
Structural type:
Product purpose: Apixaban is an oral selective activating factor X inhibitor, which can prevent thrombosis, but the adverse reaction of bleeding is lower than that of warfarin. It is used for thrombosis prevention in patients who have undergone hip or knee replacement surgery.